Unlocking the immune puzzle: study evaluates the immune impact of second booster COVID-19 vaccine

FHS
July 6, 2023
10:56 am

Researchers assessed acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant of concern (VOC).

South African regulator decides Vertex provides sufficient access to CF drugs, angering activists

After a lengthy investigation, South African regulators decided Vertex Pharmaceuticals has sufficiently provided access to its cystic fibrosis medications, ending a high-profile episode that placed

December 13, 2024

Generative AI in healthcare: Google Cloud’s Amy Waldron on the tech giant’s health ambitions

Google has been keeping busy in the healthcare industry, announcing partnerships with organizations to implement generative artificial intelligence. The search giant announced partnerships this year

August 18, 2023

Crackdowns on Unproven Stem Cell Therapies Worked Abroad

Evidence from Australia and Canada indicated that regulation can help to curb the sale of unproven stem cell therapies, researchers found. Direct-to-consumer marketplaces experienced “marked

October 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.